Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of OROSARTAN vs CODIOVAN in Essential Hypertension
NCT02433119Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Orosartan in essential hypertension, sponsored by Dong-A ST. Started Mar 2015; status: completed.
02
Drugs
Orosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02433119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433119.